For the Inventor, By the Inventor

Enter assignee name

Manhasset, NY, United States of America

The Picower Institute for Medical Research

USPTO Granted Patents = 67

Forward Citations = 1,358

Loading Chart...

Loading Chart...

40 inventors (with patents filed for the assignee):

Anthony Cerami (47 out of 167 patents)

Richard J Bucala (30 out of 57 patents)

Peter C Ulrich (27 out of 79 patents)

4. Kevin J Tracey (19 out of 93 patents)

5. Helen Vlassara (15 out of 25 patents)

6. Michael I Bukrinsky (11 out of 21 patents)

7. Marina Bianchi (10 out of 10 patents)

8. Robert A Mitchell (7 out of 9 patents)

9. Yousef Al-Abed (5 out of 40 patents)

10. Yong Ming Li (4 out of 4 patents)

11. Haichao Wang (3 out of 24 patents)

12. Jurgen Bernhagen (3 out of 5 patents)

13. Thierry F Calandra (3 out of 5 patents)

14. John J Egan (3 out of 15 patents)

15. San-Bao Hwang (3 out of 10 patents)

Core Competencies:

Immunotherapy

Glycosylation

Inflammation

Vaccine

Antibody

Cytokines

HIV Treatment

Compounds

Fibrocytes

Advanced Glycation

Mesenchymal Cells

Guanylhydrazones

67 patents: Sort by Forward Citations

1. 6759036 - Fibrocyte-base vaccine formulations (2004-07-06),

2. 6649797 - Compounds and methods of use to treat infectious diseases (2003-11-18),

3. 6645493 - Composition containing anti-MIF antibody (2003-11-11),

4. 6596851 - Inducible phosphofructokinase and the Warburg effect (2003-07-22),

5. 6538131 - Synthetic process for highly functionalized carbocyclic polyols and substituted sugar analogs (2003-03-25),

6. 6492428 - Compounds having MIF antagonist activity (2002-12-10),

7. 6420188 - Screening assay for the identification of inhibitors for macrophage migration inhibitory factor (2002-07-16),

8. 6413939 - Inducible phosphofructokinase and the Warburg effect (2002-07-02),

9. 6380165 - Immunological advanced glycation endproduct crosslink (2002-04-30),

10. 6319894 - Complexes and combinations of fetuin with therapeutic agents (2001-11-20),

11. 6297253 - Compounds and methods of use to treat infectious diseases (2001-10-02),

12. 6255046 - Inducible phosphofructokinase and the warburg effect (2001-07-03),

13. 6248787 - Guanylhydrazones and their use to treat inflammatory conditions (2001-06-19),

14. 6248356 - Immunotherapeutic anti-cancer pharmaceutical compositions (2001-06-19),

15. 6180676 - Guanylhydrazones and their use to treat inflammatory conditions (2001-01-30),

The Picower Institute for Medical Research is a leading research institute dedicated to neuroscience and advancing our understanding of the brain. Located in the Massachusetts Institute of Technology (MIT), the institute focuses on unraveling the complex mysteries of brain function and developing innovative approaches for treating neurological disorders. Through cutting-edge research, collaboration with top scientists, and state-of-the-art facilities, The Picower Institute aims to make groundbreaking discoveries that have a profound impact on human health and well-being.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 8 2026

The Picower Institute for Medical Research

67 Patents

#2 in Manhasset, NY

#323 in New York

#5,444 in US

#11,003 in the World

Manhasset, NY, United States of America

The Picower Institute for Medical Research

Forward Citations = 1,358

40 inventors:

Anthony Cerami (47 out of 167 patents)

Richard J Bucala (30 out of 57 patents)

Peter C Ulrich (27 out of 79 patents)

4. Kevin J Tracey (19 out of 93 patents)

5. Helen Vlassara (15 out of 25 patents)

Please report any incorrect information to [email protected]

Loading…